Categories Earnings, LATEST, Other Industries
Homebuilding, CalAtlantic merger boost Lennar’s Q3 results
Real estate firm Lennar Corp. (LEN) reported an increase in third-quarter earnings as strong homebuilding operations and contributions from the recently acquired CalAltantic business pushed up revenues. The results exceeded market expectations, driving the company’s stock up in premarket trading Wednesday.
Net income attributable to shareholders was $453.21 million or $1.37 per share in the August quarter, higher than $249.17 million or $1.04 per share reported a year earlier. Analysts had forecast a slower increase. Adjusted earnings, excluding special items, were $1.61 per share.
Driving the earnings growth, revenues surged 74% year-over-year to $5.67 billion during the three-month period, exceeding estimates. Homebuilding, the company’s core segment, registered an 83% growth.
The Miami-based homebuilder sold 12,613 residential units during the period, reflecting a 66% growth from the third quarter of 2017. New orders climbed 62% annually to 12,319 units, suggesting a marked increase in sales during the remainder of the year.
New orders climbed 62%, suggesting a marked increase in sales during the remainder of the year
Home sales got a boost from the strong fundamentals of the industry and the upbeat employment and wage condition, which more than offset the impact of rising prices and higher interest rates.
“With a solid balance sheet, strong cash flow generation and continued execution of our core operating strategies, we believe that we are very well positioned to continue our strong performance as we head towards the end of 2018 and into 2019,” said Stuart Miller, executive chairman of Lennar.
During the third quarter, Lennar incurred about $12 million in costs related to the acquisition of homebuilding company CalAltantic earlier this year. It also recorded an additional $140 million of integration costs in connection with the merger.
Losing about 16%, Lennar shares have been in a free fall since the beginning of the year. The stock closed the last trading session lower but jumped nearly 6% after the earnings announcement Wednesday.
Most Popular
Intensity Therapeutics is establishing a new field of localized cancer reduction: CEO
Intensity Therapeutics, Inc. (NASDAQ: INTS) is a clinical biotechnology company engaged in the discovery development, and commercialization of first-in-class cancer drugs that attenuate tumors with minimal side effects while training
INTU Earnings: Intuit Q1 2025 adj. profit rises on higher revenues
Financial technology company Intuit Inc. (NASDAQ: INTU) Thursday announced results for the first quarter of 2025, reporting a modest increase in adjusted earnings. The Mountain View-headquartered company’s first-quarter revenue came
Riding the AI wave, Nvidia looks set to stay on the high-growth path
After delivering strong results for the third quarter, Nvidia Corporation (NASDAQ: NVDA) this week said the launch of its new-generation Blackwell chip is on track. The company is thriving on